Correlation Between Collegium Pharmaceutical and Silicom

Can any of the company-specific risk be diversified away by investing in both Collegium Pharmaceutical and Silicom at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Collegium Pharmaceutical and Silicom into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Collegium Pharmaceutical and Silicom, you can compare the effects of market volatilities on Collegium Pharmaceutical and Silicom and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Collegium Pharmaceutical with a short position of Silicom. Check out your portfolio center. Please also check ongoing floating volatility patterns of Collegium Pharmaceutical and Silicom.

Diversification Opportunities for Collegium Pharmaceutical and Silicom

-0.61

Correlation Coefficient

Collegium Pharmaceutical  Silicom

Excellent diversification

The 3 months correlation between Collegium and Silicom is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Collegium Pharmaceutical and Silicom in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silicom and Collegium Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Collegium Pharmaceutical are associated (or correlated) with Silicom. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silicom has no effect on the direction of Collegium Pharmaceutical i.e., Collegium Pharmaceutical and Silicom go up and down completely randomly.

Pair Corralation between Collegium Pharmaceutical and Silicom

Given the investment horizon of 90 days Collegium Pharmaceutical is expected to under-perform the Silicom. But the stock apears to be less risky and, when comparing its historical volatility, Collegium Pharmaceutical is 1.57 times less risky than Silicom. The stock trades about -0.24 of its potential returns per unit of risk. The Silicom is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  1,311  in Silicom on October 5, 2024 and sell it today you would earn a total of  226.00  from holding Silicom or generate 17.24% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Collegium Pharmaceutical  vs.  Silicom

Collegium Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Collegium Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in February 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Silicom

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Silicom are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating essential indicators, Silicom exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Collegium Pharmaceutical and Silicom

The main advantage of trading using opposite Collegium Pharmaceutical and Silicom positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Collegium Pharmaceutical position performs unexpectedly, Silicom can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silicom will offset losses from the drop in Silicom's long position.

The idea behind Collegium Pharmaceutical and Silicom pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.